Grifols Plans US Biotech IPO, Maintains Majority Control
Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts | Health
Spanish drugmaker Grifols has decided to launch an initial public offering for its US biopharma business planning to float a minority stake while maintaining majority ownership
Spanish pharmaceutical giant Grifols is taking its US biopharma division public through an initial public offering while retaining majority ownership. The company will float a minority stake, allowing it to raise capital while keeping strategic control. This move reflects growing trends of healthcare companies restructuring to optimize valuations.
Original Article
Read full article on DevdiscourseExplore More
Related News
World Health Day 2026: Global Health at a Crossroads
Chicago Council on Global Affairs · 2026.04.13
Trump's 2027 Budget Deepens Cuts To Global And Domestic Health - Health Policy Watch
Health Policy Watch · 2026.04.12
Op-Ed: We all need public health. Public health needs you. — Waterbury Roundabout
Waterbury Roundabout · 2026.04.14
Balochistan s failing health
The Express Tribune · 2026.04.14
Perspectives on Health Data Sharing Among Patients With Somatic and Mental Health Diseases: Focus Group Study
2026.04.14
Murray students explore health careers at Mercy Health
The Paducah Sun · 2026.04.14